Related Experiment Videos
Summary
Ibuprofen pharmacokinetics follow a two-compartment model and are minimally affected by age, liver disease, or arthritis. Combining ibuprofen with acetaminophen is safe, but concurrent use with aspirin may significantly lower ibuprofen levels.
Area of Science:
- Pharmacology
- Drug Metabolism
- Clinical Pharmacokinetics
Background:
- Understanding drug behavior in the body is crucial for safe and effective medication use.
- Ibuprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID).
Purpose of the Study:
- To describe the pharmacokinetic profile of ibuprofen.
- To investigate factors influencing ibuprofen pharmacokinetics, including age, liver disease, rheumatoid arthritis, and drug interactions.
Main Methods:
- Pharmacokinetic modeling (two-compartment open model).
- Analysis of ibuprofen levels in plasma and breast milk.
- Evaluation of drug interactions with acetaminophen and aspirin.
Main Results:
- Ibuprofen exhibits two-compartment open model pharmacokinetics.
- Minimal impact of advanced age, alcoholic liver disease, or rheumatoid arthritis on ibuprofen levels.
- Negligible ibuprofen transfer into breast milk.
- No alteration in ibuprofen pharmacokinetics when co-administered with acetaminophen.
- Potential significant reduction in ibuprofen plasma levels when used concurrently with aspirin.
Conclusions:
- Ibuprofen's pharmacokinetics are generally stable across various patient populations and with acetaminophen co-administration.
- Concomitant use of ibuprofen and aspirin warrants caution due to potential interactions affecting ibuprofen efficacy.